UK Regulator Targets Delays in Rare Disease Treatments – Medscape

1. UK Regulator Targets Delays in Rare Disease Treatments  Medscape
2. Major change for rare disease treatments on way, signals MHRA  GOV.UK
3. MHRA set to overhaul the UK’s rare disease drug regulatory pathway  European Pharmaceutical Review
4. New drugs to be approved faster so patients don’t wait years  The Times
5. MHRA reforms will speed up path for rare therapies  Healthcare Management Magazine

Continue Reading